// App-Quantinova.ai

587P : Survival by sidedness of metastatic colorectal cancer (mCRC) treated with epidermal growth factor receptor antibodies (EGFR-Ab) in the refractory setting: A population-based study of 1509 patients

Researchers

Presenter

  • E.Segelov

Principal Investigators

  • C.Earle

  • A.P.Venook

  • R.Saskin

  • L.Mofid

  • S.Singh

Medical Centers

  • Medical Oncology, Monash University and Monash Health, Melbourne, Australia

  • Medical Oncology, Sunnybrook Odette Cancer Center, Sunnybrook HSC, Toronto, ON, Canada

  • Medical Oncology and Translational Research, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA

  • Institute of Clinical Evaluative Sciences, Toronto, ON, Canada

Locations

  • Australia

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • panitumumab

  • Erbitux

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved